| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics
|
Aug 11, 2026 | HOLD |
Buy
-8.0% avg upside
19 analysts
|
$135.00
0.29% Upside
|
+0.0% | · |
|
DMRA
Damora Therapeutics
|
Aug 11, 2026 | BUY |
Strong Buy
-4.7% avg upside
20 analysts
|
$40.00
31.66% Upside
|
· | · |
|
IRON
Disc Medicine
|
Aug 11, 2026 | BUY |
Strong Buy
+7.2% avg upside
21 analysts
|
$88.00
8.36% Upside
|
· | · |
|
COGT
Cogent Biosciences
|
Aug 11, 2026 | BUY |
Strong Buy
-4.4% avg upside
26 analysts
|
$55.00
42.07% Upside
|
+0.0% | · |
|
SYRE
Spyre Therapeutics
|
Aug 11, 2026 | BUY |
Strong Buy
-8.7% avg upside
23 analysts
|
$130.00
26.47% Upside
|
· | · |
|
XNCR
Xencor
|
Aug 06, 2026 | BUY |
Strong Buy
+56.5% avg upside
27 analysts
|
$30.00
35.77% Upside
|
+13.8% | · |
|
BEAM
Beam Therapeutics
|
Aug 05, 2026 | BUY |
Strong Buy
+93.4% avg upside
25 analysts
|
$65.00
142.00% Upside
|
+0.2% | · |
|
ODTX
Odyssey Therapeutics, Inc.
|
Aug 05, 2026 | BUY |
Strong Buy
+62.2% avg upside
5 analysts
|
$30.00
47.51% Upside
|
+1.3% | · |
|
CATX
Perspective Therapeutics
|
Aug 03, 2026 | BUY |
Strong Buy
+252.3% avg upside
22 analysts
|
$11.00
245.89% Upside
|
+5.7% | · |
|
KNSA
Kiniksa Pharmaceuticals
|
Jul 28, 2026 | BUY |
Strong Buy
-0.8% avg upside
11 analysts
|
$99.00
27.18% Upside
|
-1.8% | · |
|
ARGX
Argenx Se
|
Jul 28, 2026 | BUY |
Strong Buy
-9.3% avg upside
47 analysts
|
$1050.00
21.48% Upside
|
+0.8% | · |
|
NVCR
NovoCure
|
Jul 24, 2026 | HOLD |
Strong Buy
+182.8% avg upside
11 analysts
|
$20.00
13.32% Upside
|
-1.2% | · |
|
NUVB
Nuvation Bio
|
Jul 21, 2026 | BUY |
Strong Buy
+110.5% avg upside
15 analysts
|
$11.00
72.60% Upside
|
-1.7% | · |
|
COAG
Hemab Therapeutics Holdings, Inc.
|
Jul 13, 2026 | BUY |
Strong Buy
+0.5% avg upside
5 analysts
|
$55.00
6.34% Upside
|
+25.7% | · |
|
ABVX
Abivax SA Sponsored ADR
|
Jul 06, 2026 | HOLD |
Strong Buy
+6.0% avg upside
15 analysts
|
$140.00
10.43% Upside
|
-12.8% | · |
|
TCRX
TScan Therapeutics
|
Jun 23, 2026 | BUY |
Strong Buy
+995.3% avg upside
12 analysts
|
$5.00
543.74% Upside
|
-17.4% | · |
|
STRO
Sutro Biopharma
|
May 18, 2026 | BUY |
Strong Buy
+57.7% avg upside
21 analysts
|
$60.00
139.72% Upside
|
-26.0% | · |
|
ZBIO
Zenas BioPharma, Inc.
|
May 14, 2026 | BUY |
Strong Buy
+32.0% avg upside
11 analysts
|
$45.00
38.67% Upside
|
+65.6% | · |
|
ORKA
Oruka Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
+20.5% avg upside
16 analysts
|
$165.00
57.56% Upside
|
+63.8% | · |
|
BBOT
BridgeBio Oncology Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+172.3% avg upside
10 analysts
|
$25.00
171.80% Upside
|
+14.8% | · |
|
STTK
Shattuck Labs
|
May 08, 2026 | BUY |
Strong Buy
+199.0% avg upside
15 analysts
|
$11.00
53.18% Upside
|
+9.3% | · |
|
ANAB
AnaptysBio
|
Mar 31, 2026 | BUY |
Strong Buy
+26.8% avg upside
26 analysts
|
$75.00
29.68% Upside
|
+55.2% | · |
|
EWTX
Edgewise Therapeutics
|
Mar 17, 2026 | BUY |
Strong Buy
+3.6% avg upside
15 analysts
|
$32.00
27.84% Downside
|
+43.1% | · |
|
ARTV
Artiva Biotherapeutics, Inc.
|
Mar 11, 2026 | BUY |
Strong Buy
+159.7% avg upside
7 analysts
|
$23.00
95.15% Upside
|
+65.2% | · |
|
ORIC
Oric Pharmaceuticals
|
Feb 24, 2026 | BUY |
Strong Buy
+73.7% avg upside
19 analysts
|
$20.00
45.65% Upside
|
+2.5% | · |
|
SE:HNSA
Hansa Biopharma AB
|
Jan 07, 2026 | BUY |
Strong Buy
+242.6% avg upside
4 analysts
|
$69.00
70.47% Upside
|
+15.5% | · |
|
RARE
Ultragenyx Pharmaceutical
|
Oct 14, 2025 | HOLD |
Strong Buy
+147.0% avg upside
36 analysts
|
$35.00
29.73% Upside
|
-15.2% | · |
|
VOR
Vor Biopharma
|
Jun 26, 2025 | HOLD |
Buy
+85.5% avg upside
17 analysts
|
$8.00
66.16% Downside
|
-9.6% | · |
|
BCAX
Bicara Therapeutics Inc.
|
May 23, 2025 | BUY |
Strong Buy
+29.6% avg upside
14 analysts
|
$30.00
26.28% Upside
|
+133.9% | · |
|
FATE
Fate Therapeutics
|
May 14, 2025 | HOLD |
Buy
+340.0% avg upside
31 analysts
|
$5.00
82.38% Upside
|
+97.9% | · |
|
IMNM
Immunome
|
Mar 20, 2025 | BUY |
Strong Buy
+29.4% avg upside
16 analysts
|
$33.00
25.62% Upside
|
+131.1% | · |
|
SRRK
Scholar Rock Holding
|
Mar 17, 2025 | BUY |
Strong Buy
+10.0% avg upside
23 analysts
|
$50.00
4.02% Downside
|
+17.2% | · |
|
IMA
ImageneBio
|
Aug 09, 2024 | HOLD |
Buy
+199.0% avg upside
12 analysts
|
$2.00
64.40% Downside
|
-24.8% | · |
|
PRME
Prime Medicine, Inc.
|
Apr 02, 2024 | BUY |
Strong Buy
+204.3% avg upside
16 analysts
|
$12.00
268.08% Upside
|
-71.7% | · |
|
KPTI
Karyopharm Therapeutics
|
Jul 26, 2023 | HOLD |
Strong Buy
+839.6% avg upside
18 analysts
|
$4.00
90.50% Upside
|
-43.9% | · |
|
TECX
Tectonic Therapeutic
|
Jul 12, 2023 | HOLD |
Strong Buy
+75.7% avg upside
24 analysts
|
$2.00
93.63% Downside
|
-1.3% | · |
|
DNTH
Dianthus Therapeutics
|
Jan 26, 2023 | HOLD |
Strong Buy
-10.4% avg upside
29 analysts
|
$16.00
85.22% Downside
|
+154.0% | · |
|
FENC
Fennec Pharmaceuticals
|
Jan 25, 2023 | BUY |
Strong Buy
+27.1% avg upside
9 analysts
|
$17.00
33.04% Upside
|
+4.7% | · |
|
NTLA
Intellia Therapeutics
|
Nov 03, 2022 | HOLD |
Buy
+221.7% avg upside
37 analysts
|
$53.00
340.91% Upside
|
-44.3% | · |
|
MGNX
MacroGenics
|
Jun 16, 2021 | BUY |
Buy
+345.6% avg upside
25 analysts
|
$32.00
716.38% Upside
|
-89.2% | · |
|
GB:0QW0
arGEN X
|
Mar 04, 2021 | BUY |
Strong Buy
-19.2% avg upside
24 analysts
|
$301.41
59.88% Downside
|
-3.7% | · |
|
SYRS
Syros Pharmaceuticals
|
Aug 07, 2020 | HOLD |
Buy
+2349900.0% avg upside
9 analysts
|
$10.00
1999900.00% Upside
|
· | · |
|
VYGR
Voyager Therapeutics
|
Jun 18, 2019 | BUY |
Strong Buy
+347.0% avg upside
23 analysts
|
$36.00
1024.96% Upside
|
-53.2% | · |
|
DDS
Dillard's
|
Aug 16, 2018 | BUY |
Sell
-52.1% avg upside
8 analysts
|
$95.00
85.25% Downside
|
-26.6% | · |
|
PRTA
Prothena
|
Apr 23, 2018 | HOLD |
Buy
+152.9% avg upside
14 analysts
|
$13.00
41.00% Upside
|
-2.8% | · |
|
KURA
Kura Oncology
|
Dec 21, 2017 | BUY |
Strong Buy
+161.6% avg upside
26 analysts
|
$19.00
91.29% Upside
|
-13.1% | · |
|
SYBX
Synlogic
|
Nov 28, 2017 | BUY |
Buy
+1939.9% avg upside
11 analysts
|
$20.00
1594.93% Upside
|
· | · |
|
ARDX
Ardelyx
|
Oct 12, 2017 | BUY |
Strong Buy
+239.9% avg upside
21 analysts
|
$16.00
306.10% Upside
|
-52.6% | · |
|
NOVN
Novan
|
Jan 30, 2017 | HOLD |
Buy
6 analysts
|
$6.00
|
· | · |
|
IRWD
Ironwood Pharma
|
Oct 24, 2016 | HOLD |
Buy
+178.5% avg upside
23 analysts
|
$13.00
202.35% Upside
|
+7.6% | · |
|
INFIQ
Infinity Pharmaceuticals
|
Aug 10, 2016 | HOLD |
Buy
+647142757.1% avg upside
8 analysts
|
$1.00
99999900.06% Upside
|
· | · |
|
LITS
Lite Strategy
|
Aug 03, 2016 | HOLD |
Buy
+1110.4% avg upside
13 analysts
|
$2.00
122.00% Upside
|
· | · |
|
CLDX
Celldex
|
May 09, 2016 | HOLD |
Strong Buy
-6.9% avg upside
28 analysts
|
$3.00
93.33% Downside
|
-19.4% | · |
|
DARE
Daré Bioscience
|
Nov 17, 2015 | BUY |
Strong Buy
+843.9% avg upside
14 analysts
|
$9.00
524.91% Upside
|
· | · |
|
INSM
Insmed
|
Mar 31, 2014 | SELL |
Strong Buy
+33.2% avg upside
37 analysts
|
— | -9.2% | · |
|
BAX
Baxter International
|
Mar 22, 2013 | HOLD |
Buy
+21.2% avg upside
23 analysts
|
— | -1.8% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.